Dimethylamine → 1-{(1S,4R)-4-[3-(4-Aza-spiro[2.5]oct-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-6-yloxy]-1,2,3,4-tetrahydro-naphthalen-1-yl}-3-{5-tert-butyl-2-[3-(2-dimethylamino-ethoxy)-phenyl]-2H-pyrazol-3-yl}-urea formate salt

HRID 1402418Notes

Reaction equation

HRID 1402418 reaction equation
[CH2:1]1[C:3]2([CH2:8][CH2:7][CH2:6][CH2:5][N:4]2[C:9]2[N:13]3[CH:14]=[C:15]([O:18][C@H:19]4[C:28]5[C:23](=[CH:24][CH:25]=[CH:26][CH:27]=5)[C@@H:22]([NH:29][C:30](=[O:55])[NH:31][C:32]5[N:36]([C:37]6[CH:38]=[C:39]([CH:48]=[CH:49][CH:50]=6)[O:40][CH2:41][CH2:42]OS(C)(=O)=O)[N:35]=[C:34]([C:51]([CH3:54])([CH3:53])[CH3:52])[CH:33]=5)[CH2:21][CH2:20]4)[CH:16]=[CH:17][C:12]3=[N:11][N:10]=2)[CH2:2]1.[CH3:56][NH:57][CH3:58].C1C[O:62]CC1>>[CH:30]([OH:55])=[O:62].[CH2:2]1[C:3]2([CH2:8][CH2:7][CH2:6][CH2:5][N:4]2[C:9]2[N:13]3[CH:14]=[C:15]([O:18][C@H:19]4[C:28]5[C:23](=[CH:24][CH:25]=[CH:26][CH:27]=5)[C@@H:22]([NH:29][C:30]([NH:31][C:32]5[N:36]([C:37]6[CH:50]=[CH:49][CH:48]=[C:39]([O:40][CH2:41][CH2:42][N:57]([CH3:58])[CH3:56])[CH:38]=6)[N:35]=[C:34]([C:51]([CH3:53])([CH3:54])[CH3:52])[CH:33]=5)=[O:55])[CH2:21][CH2:20]4)[CH:16]=[CH:17][C:12]3=[N:11][N:10]=2)[CH2:1]1

Participants

4

Procedure

A brown solution of Intermediate 148g (0.099 mmol) and dimethylamine (2M in THF, 0.99 mL, 1.98 mmol) in THF (1 mL) was stirred in a sealed vial at 60° C. for 16 h. The solution was decanted and concentrated. MDAP (Method 7) gave the title compound as a pale yellow solid (50 mg, 65%). LCMS (Method 5): Rt 3.62 min, m/z 718.6 [MH+]. 1H NMR (400 MHz, d6-DMSO): 0.42-0.53 (4H, m), 1.27 (9H, s), 1.53-1.61 (2H, m), 1.74-1.96 (6H, m), 1.99-2.15 (2H, m), 2.20 (6H, s), 2.63 (2H, t, J=5.8 Hz), 3.22-3.29 (2H, m), 4.09 (2H, t, J=5.8 Hz), 4.81 (1H, td, J=8.6, 5.5 Hz), 5.48 (1H, t, J=4.3 Hz), 6.33 (1H, s), 6.95-6.98 (1H, m), 7.06-7.12 (3H, m), 7.14 (1H, dd, J=9.9, 2.2 Hz), 7.25-7.42 (5H, m), 7.56 (1H, d, J=2.1 Hz), 7.61 (1H, dd, J=9.8, 0.8 Hz), 8.12 (1H, s), 8.17 (1.4H, s).

Workup

  1. customThe solution was decanted
  2. concentrationconcentrated

Sources & evidence

ORD record
ord-2797776cf5a848c1bf75329ab8297c5e
Source dataset
uspto-grants-2014_12
Patent number
US08907094B2

Reaction notes

Loading…